FIELD: chemistry.
SUBSTANCE: visualisation agent contains a conjugate of formula (I) of benzopyrylium dye through a linker group with a 3-100-dimensional synthetic peptide which provides directed delivery to the biological target. Also disclosed is a pharmaceutical composition which contains said conjugate of formula (I), a set for preparing said pharmaceutical composition and methods for visualisation of a mammal body in vivo.
EFFECT: invention provides efficient visualisation of a mammal body in vivo while monitoring diseased state thereof.
24 cl, 5 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OPTICAL AGENTS OF VISUALISATION | 2008 |
|
RU2475266C2 |
| MARKED PEPTIDES BINDING HEPATOCYTE GROWTH FACTOR (HGF) FOR VISUALISATION | 2008 |
|
RU2473361C9 |
| PEPTIDE COMPOSITION OF RADIOACTIVE INDICATORS | 2011 |
|
RU2594167C2 |
| COMPOSITION FOR OPTICAL VISUALIZATION, METHOD OF ITS PRODUCTION AND USE | 2019 |
|
RU2802481C2 |
| PEPTIDE COMPOUNDS | 2005 |
|
RU2393167C2 |
| VISUALISATION TECHNIQUE | 2008 |
|
RU2505316C2 |
| IMPROVED CONJUGATES N4 OF CHELATING AGENTS | 2005 |
|
RU2360701C2 |
| CONTRAST AGENT AIMED AT UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR | 2005 |
|
RU2394837C2 |
| TAGGED MOLECULAR VISUALISING AGENTS, METHODS FOR PREPARING AND METHODS FOR USING | 2010 |
|
RU2523411C2 |
| PEPTIDE-BASED COMPOUNDS FOR DIRECTED TRANSPORT TO INTEGRIN RECEPTORS | 2002 |
|
RU2303042C2 |
